[Combined treatment of uterine cancer using preoperative intracavitary gamma therapy]

N I Okeanova, Okeanova Ni, E E Vishnevskaia, Vishnevskaia Ee
Voprosy onkologii · 1984 · vol. 30(9) , pp. 76–80 · PMID:6495699 · W2444620926
Non-randomised trial OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-18 ⓘ

Preoperative intracavitary gamma therapy for 212 uterine cancer patients induced partial tumor regression, facilitated surgery without increasing complications, and improved combined treatment effectiveness.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Low-fractionated intracavitary gamma-therapy from the AGAT-B installation was given to 212 patients as the initial component of combined treatment. The treatment was well tolerated and was followed by a partial regression of tumor. It did not interfere with surgical intervention nor did it involve an increase in postoperative complication incidence. Application of the procedure raises the effectiveness of combined treatment of uterine cancer.

My notes (saved in your browser only)

MeSH descriptors

Adenocarcinoma Brachytherapy Uterine Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Combined Modality Therapy Female Gamma Rays Humans Hysterectomy Middle Aged Postoperative Complications Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:15.129929+00:00
License: CC0 · commercial use OK